NCT06416267View on ClinicalTrials.gov

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

Not yet recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2040

Study Completion Date

December 31, 2040

Conditions
Monoclonal B-Cell LymphocytosisChronic Lymphocytic LeukemiaInfectionsCancersCardiovascular DiseasesAlzheimer DiseaseDementiaAutoimmune DiseasesParkinson Disease
Sponsors

Collaborators (1)

Bnai Zion Medical Center
All Listed Sponsors
collaborator

Clalit Health Services, Haifa and West Galilee

OTHER

collaborator

Bnai Zion Medical Center

OTHER_GOV

lead

University of Haifa

OTHER